1995
DOI: 10.1128/jcm.33.6.1660-1661.1995
|View full text |Cite
|
Sign up to set email alerts
|

Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome

Abstract: We analyzed lymphocytes of patients with chronic fatigue syndrome (CFS) for the presence of human herpesvirus 6 (HHV-6) and HHV-7 DNA. HHV-7 was present in over 80% of CFS patients and healthy controls, while the prevalence of HHV-6 variant A increased significantly in CFS cases (22 versus 4%; P ‫؍‬ 0.05).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
21
2
3

Year Published

1996
1996
2001
2001

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 75 publications
(28 citation statements)
references
References 13 publications
(9 reference statements)
2
21
2
3
Order By: Relevance
“…Data from both the civilian and veteran study populations confirmed this observation. In the literature, there are both positive (7,8,22,31) and negative (1,11,24,28) data with regard to correlation between the detection of HHV6 DNA in PBMCs of CFS patients versus healthy controls. Our present data clearly support the latter view, in that despite the use of well-characterized longterm CFS patients and an age-, race-, and gender-matched control population, there were no significant differences observed.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Data from both the civilian and veteran study populations confirmed this observation. In the literature, there are both positive (7,8,22,31) and negative (1,11,24,28) data with regard to correlation between the detection of HHV6 DNA in PBMCs of CFS patients versus healthy controls. Our present data clearly support the latter view, in that despite the use of well-characterized longterm CFS patients and an age-, race-, and gender-matched control population, there were no significant differences observed.…”
Section: Discussionmentioning
confidence: 99%
“…The primer annealing temperature was increased to 58°C and the optimum MgCl 2 concentration was determined to be 4.5 mM. The HHV7 primers used, denoted HHV7 #1 and HHV7 #2 (Table 1), amplify a 124-bp region of a conserved gene named ORF U10 (5,11). These primers are specific for HHV7 DNA alone and do not cross-react with EBV, HCMV, or either strain of HHV6 (data not shown).…”
mentioning
confidence: 99%
“…HHV-6 may be considered ubiquitous in the human population, although some epidemiological studies in the past may have used reagents (employed to detect HHV-6 only), which may have cross-reacted with the closely related HHV-7 [Berneman et al, 1993;Ablashi et al, 1995;Di Luca et al, 1995]. Depending on geographic location, seropositivity may be greater than 80% by immunofluorescence assay (IFA) tested anti-HHV-6-IgG antibody titers of >1:20 [Levy et al, 1990;Krueger et al, 1994;Krueger et al, 1995].…”
Section: Discussionmentioning
confidence: 99%
“…The lymphotropic virus infects almost all children by the age of 2 years usually causing a lifelong latency. Independent of the patient's age HHV-6 infection has been associated with a number of neurologic conditions [Suga et al, 1993], including recurrent febrile seizures and convulsions [Kondo et al, 1993], status epilepticus [Jones et al, 1994], meningitis [Huang et al, 1991], myalgic encephalomyelitis [Wakefield et al, 1989], meningoencephalitis [Ishiguro et al, 1990;, encephalitis Kehl Knox et al, 1992], encephalopathy [Gloning et al, 1991;Asano et al, 1992], multiple sclerosis [Wilborn et al, 1994;Challoner et al, 1995], and chronic fatigue syndrome [Buchwald et al, 1992;Di Luca et al, 1995]. One work group suggests that the central nervous system may be a site of HHV-6 persistence, and that peripheral blood mononuclear cells do not play a role in hibernation of the virus [Caserta et al, 1994].…”
Section: Discussionmentioning
confidence: 99%
“…Med. 36:157, 1997]), fulminant hepatitis (43) Epstein-Barr virus-negative infectious mononucleosis (4,45), chronic fatigue syndrome (9,16,37), and, more recently, multiple sclerosis (2,3,11,29,44). A large body of evidence suggests that HHV-6 may act as an opportunistic agent in patients with immunodeficiencies, particularly those who have undergone bone marrow or organ transplantation (10,15,18,19,42) and human immunodeficiency virus-infected individuals (1,17,20,28,41).…”
mentioning
confidence: 99%